BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

754 related articles for article (PubMed ID: 15339043)

  • 1. CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion.
    Kucia M; Jankowski K; Reca R; Wysoczynski M; Bandura L; Allendorf DJ; Zhang J; Ratajczak J; Ratajczak MZ
    J Mol Histol; 2004 Mar; 35(3):233-45. PubMed ID: 15339043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the SDF-1-CXCR4 axis.
    Kucia M; Reca R; Miekus K; Wanzeck J; Wojakowski W; Janowska-Wieczorek A; Ratajczak J; Ratajczak MZ
    Stem Cells; 2005 Aug; 23(7):879-94. PubMed ID: 15888687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CXCR4-SDF-1 signaling is active in rhabdomyosarcoma cells and regulates locomotion, chemotaxis, and adhesion.
    Libura J; Drukala J; Majka M; Tomescu O; Navenot JM; Kucia M; Marquez L; Peiper SC; Barr FG; Janowska-Wieczorek A; Ratajczak MZ
    Blood; 2002 Oct; 100(7):2597-606. PubMed ID: 12239174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stromal cell-derived factor-1 and CXCR4 receptor interaction in tumor growth and metastasis of breast cancer.
    Dewan MZ; Ahmed S; Iwasaki Y; Ohba K; Toi M; Yamamoto N
    Biomed Pharmacother; 2006 Jul; 60(6):273-6. PubMed ID: 16828253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Galpha13-Rho signaling axis is required for SDF-1-induced migration through CXCR4.
    Tan W; Martin D; Gutkind JS
    J Biol Chem; 2006 Dec; 281(51):39542-9. PubMed ID: 17056591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pleiotropic effects of the SDF-1-CXCR4 axis in organogenesis, regeneration and tumorigenesis.
    Ratajczak MZ; Zuba-Surma E; Kucia M; Reca R; Wojakowski W; Ratajczak J
    Leukemia; 2006 Nov; 20(11):1915-24. PubMed ID: 16900209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of chemokine receptor 4/stromal cell-derived factor 1 system during osteosarcoma tumor progression.
    Perissinotto E; Cavalloni G; Leone F; Fonsato V; Mitola S; Grignani G; Surrenti N; Sangiolo D; Bussolino F; Piacibello W; Aglietta M
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):490-7. PubMed ID: 15701832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXCL12 (SDF-1)/CXCR4 pathway in cancer.
    Teicher BA; Fricker SP
    Clin Cancer Res; 2010 Jun; 16(11):2927-31. PubMed ID: 20484021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1.
    Ceradini DJ; Kulkarni AR; Callaghan MJ; Tepper OM; Bastidas N; Kleinman ME; Capla JM; Galiano RD; Levine JP; Gurtner GC
    Nat Med; 2004 Aug; 10(8):858-64. PubMed ID: 15235597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The axis of evil in the fight against cancer.
    Petrushev B; Tomuleasa C; Suşman S; Sorişău O; Aldea M; Kacsó G; Buigă R; Irimie A
    Rom J Intern Med; 2011; 49(4):319-25. PubMed ID: 22568277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stromal cell-derived factor-1 binding to its chemokine receptor CXCR4 on precursor cells promotes the chemotactic recruitment, development and survival of human osteoclasts.
    Wright LM; Maloney W; Yu X; Kindle L; Collin-Osdoby P; Osdoby P
    Bone; 2005 May; 36(5):840-53. PubMed ID: 15794931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemokine receptor CXCR4: role in gastrointestinal cancer.
    Lombardi L; Tavano F; Morelli F; Latiano TP; Di Sebastiano P; Maiello E
    Crit Rev Oncol Hematol; 2013 Dec; 88(3):696-705. PubMed ID: 24120239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological role of the CXCR4-SDF-1 axis in normal human hematopoietic cells.
    Majka M; Ratajczak MZ
    Methods Mol Biol; 2006; 332():103-14. PubMed ID: 16878687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of cellular proliferation, cytoskeletal function, and signal transduction through CXCR4 and c-Kit in small cell lung cancer cells.
    Kijima T; Maulik G; Ma PC; Tibaldi EV; Turner RE; Rollins B; Sattler M; Johnson BE; Salgia R
    Cancer Res; 2002 Nov; 62(21):6304-11. PubMed ID: 12414661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of the SDF-1-CXCR4 axis by the third complement component (C3)--implications for trafficking of CXCR4+ stem cells.
    Ratajczak MZ; Reca R; Wysoczynski M; Yan J; Ratajczak J
    Exp Hematol; 2006 Aug; 34(8):986-95. PubMed ID: 16863905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progression.
    Sun X; Cheng G; Hao M; Zheng J; Zhou X; Zhang J; Taichman RS; Pienta KJ; Wang J
    Cancer Metastasis Rev; 2010 Dec; 29(4):709-22. PubMed ID: 20839032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The critical role of SDF-1/CXCR4 axis in cancer and cancer stem cells metastasis.
    Gelmini S; Mangoni M; Serio M; Romagnani P; Lazzeri E
    J Endocrinol Invest; 2008 Sep; 31(9):809-19. PubMed ID: 18997494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of stromal-derived factor-1--CXCR7 axis in development and cancer.
    Maksym RB; Tarnowski M; Grymula K; Tarnowska J; Wysoczynski M; Liu R; Czerny B; Ratajczak J; Kucia M; Ratajczak MZ
    Eur J Pharmacol; 2009 Dec; 625(1-3):31-40. PubMed ID: 19835865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of ligand-receptor system between stromal-cell-derived factor-1 and CXC chemokine receptor 4 in human prostate cancer: a possible predictor of metastasis.
    Mochizuki H; Matsubara A; Teishima J; Mutaguchi K; Yasumoto H; Dahiya R; Usui T; Kamiya K
    Biochem Biophys Res Commun; 2004 Jul; 320(3):656-63. PubMed ID: 15240098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A possible role for CXCR4 and its ligand, the CXC chemokine stromal cell-derived factor-1, in the development of bone marrow metastases in neuroblastoma.
    Geminder H; Sagi-Assif O; Goldberg L; Meshel T; Rechavi G; Witz IP; Ben-Baruch A
    J Immunol; 2001 Oct; 167(8):4747-57. PubMed ID: 11591806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.